Formulating Poorly Water Soluble Drugs

Nonfiction, Health & Well Being, Medical, Specialties, Pharmacy, Science & Nature, Technology, Engineering, Chemical & Biochemical
Cover of the book Formulating Poorly Water Soluble Drugs by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319426099
Publisher: Springer International Publishing Publication: December 16, 2016
Imprint: Springer Language: English
Author:
ISBN: 9783319426099
Publisher: Springer International Publishing
Publication: December 16, 2016
Imprint: Springer
Language: English

The objective of this volume is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist’s approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound’s physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at minimum a working knowledge of each of the abovementioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The objective of this volume is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist’s approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound’s physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at minimum a working knowledge of each of the abovementioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop

More books from Springer International Publishing

Cover of the book Galician Migrations: A Case Study of Emerging Super-diversity by
Cover of the book Learning and Collaboration Technologies. Designing Learning Experiences by
Cover of the book Endogenous ADP-Ribosylation by
Cover of the book Multidetector-Row CT of the Thorax by
Cover of the book The Practical Import of Political Inquiry by
Cover of the book Sound Analysis and Synthesis with R by
Cover of the book Local Cosmopolitanism by
Cover of the book Bioremediation in Latin America by
Cover of the book Real-time Speech and Music Classification by Large Audio Feature Space Extraction by
Cover of the book Innovations in Bio-Inspired Computing and Applications by
Cover of the book The Practice of Enterprise Modeling by
Cover of the book Lithostratigraphy of Iran by
Cover of the book Harvesting Rainwater from Buildings by
Cover of the book Search and Optimization by Metaheuristics by
Cover of the book Artificial Neural Networks and Machine Learning – ICANN 2016 by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy